KATERZIA

Generic: AMLODIPINE

Manufacturer: Azurity Pharmaceuticals, Inc.

Dihydropyridine Calcium Channel Blocker [EPC]Calcium Channel Blocker [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Proton Pump Inhibitor [EPC]
257,844
Total Reports
98,713
Serious Reports
28,133
Death Reports
30
Reported Reactions
Death Report Ratio: High (10.91%)

Patient Demographics

Male
111,128
Female
125,200

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for KATERZIA.

# Reaction Reports % of Total
1 FATIGUE 15,695
6.1%
2 DIARRHOEA 14,039
5.5%
3 NAUSEA 13,426
5.2%
4 DYSPNOEA 13,218
5.1%
5 DRUG INEFFECTIVE 12,075
4.7%
6 OFF LABEL USE 11,241
4.4%
7 DIZZINESS 10,672
4.2%
8 HEADACHE 9,888
3.8%
9 ACUTE KIDNEY INJURY 9,366
3.6%
10 PAIN 9,170
3.6%
11 VOMITING 8,739
3.4%
12 FALL 8,492
3.3%
13 ASTHENIA 8,485
3.3%
14 HYPOTENSION 8,363
3.3%
15 MALAISE 7,952
3.1%
16 DEATH 7,772
3.0%
17 HYPERTENSION 7,763
3.0%
18 ARTHRALGIA 7,651
3.0%
19 PNEUMONIA 7,475
2.9%
20 COUGH 6,411
2.5%
21 RASH 6,284
2.4%
22 BLOOD PRESSURE INCREASED 6,222
2.4%
23 PAIN IN EXTREMITY 6,206
2.4%
24 WEIGHT DECREASED 5,968
2.3%
25 TOXICITY TO VARIOUS AGENTS 5,919
2.3%
26 PRURITUS 5,891
2.3%
27 DRUG INTERACTION 5,844
2.3%
28 DECREASED APPETITE 5,773
2.2%
29 PYREXIA 5,725
2.2%
30 CHRONIC KIDNEY DISEASE 5,370
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.